Novel RNAi Therapy Silences Mutated Huntington's Disease Gene and Reduces Symptoms

May 21, 2014 - NEW ROCHELLE, N.Y. -- A targeted gene silencing strategy blocks production of the dysfunctional huntingtin protein, the cause of Huntington's disease, a fatal, inherited neurodegenerative disorder.



via New Rochelle Newswire http://ift.tt/TuhkOY